293 related articles for article (PubMed ID: 29735427)
1. Heterocycles: Versatile control elements in bioactive macrocycles.
Soor HS; Appavoo SD; Yudin AK
Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
[TBL] [Abstract][Full Text] [Related]
2. Property-Driven Development of Passively Permeable Macrocyclic Scaffolds Using Heterocycles.
Saunders GJ; Yudin AK
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206866. PubMed ID: 35687524
[TBL] [Abstract][Full Text] [Related]
3. Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products.
Bockus AT; Lexa KW; Pye CR; Kalgutkar AS; Gardner JW; Hund KC; Hewitt WM; Schwochert JA; Glassey E; Price DA; Mathiowetz AM; Liras S; Jacobson MP; Lokey RS
J Med Chem; 2015 Jun; 58(11):4581-9. PubMed ID: 25950816
[TBL] [Abstract][Full Text] [Related]
4. Advances in macrocyclic peptide-based antibiotics.
Luther A; Bisang C; Obrecht D
Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
[TBL] [Abstract][Full Text] [Related]
5. Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle.
Zhang C; Liu F; Zhang Y; Song C
Eur J Med Chem; 2024 Mar; 268():116234. PubMed ID: 38401189
[TBL] [Abstract][Full Text] [Related]
6. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
Giordanetto F; Kihlberg J
J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773
[TBL] [Abstract][Full Text] [Related]
7. Nature Builds Macrocycles and Heterocycles into Its Antimicrobial Frameworks: Deciphering Biosynthetic Strategy.
Walsh CT
ACS Infect Dis; 2018 Sep; 4(9):1283-1299. PubMed ID: 29993235
[TBL] [Abstract][Full Text] [Related]
8. Achieving Skeletal Diversity in Peptide Macrocycles through The Use of Heterocyclic Grafts.
Kaldas SJ; Yudin AK
Chemistry; 2018 May; 24(28):7074-7082. PubMed ID: 29363202
[TBL] [Abstract][Full Text] [Related]
9. Lead discovery and optimization strategies for peptide macrocycles.
Bhat A; Roberts LR; Dwyer JJ
Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
[TBL] [Abstract][Full Text] [Related]
10. Conformational Strain of Macrocyclic Peptides in Ligand-Receptor Complexes Based on Advanced Refinement of Bound-State Conformers.
Brueckner AC; Deng Q; Cleves AE; Lesburg CA; Alvarez JC; Reibarkh MY; Sherer EC; Jain AN
J Med Chem; 2021 Mar; 64(6):3282-3298. PubMed ID: 33724820
[TBL] [Abstract][Full Text] [Related]
11. Frontier Between Cyclic Peptides and Macrocycles.
Ermert P; Luther A; Zbinden P; Obrecht D
Methods Mol Biol; 2019; 2001():147-202. PubMed ID: 31134572
[TBL] [Abstract][Full Text] [Related]
12. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.
Chen IJ; Foloppe N
Bioorg Med Chem; 2013 Dec; 21(24):7898-920. PubMed ID: 24184215
[TBL] [Abstract][Full Text] [Related]
13. Disulfide-rich macrocyclic peptides as templates in drug design.
Northfield SE; Wang CK; Schroeder CI; Durek T; Kan MW; Swedberg JE; Craik DJ
Eur J Med Chem; 2014 Apr; 77():248-57. PubMed ID: 24650712
[TBL] [Abstract][Full Text] [Related]
14. Protein epitope mimetic macrocycles as biopharmaceuticals.
Luther A; Moehle K; Chevalier E; Dale G; Obrecht D
Curr Opin Chem Biol; 2017 Jun; 38():45-51. PubMed ID: 28319811
[TBL] [Abstract][Full Text] [Related]
15. Building upon Nature's Framework: Overview of Key Strategies Toward Increasing Drug-Like Properties of Natural Product Cyclopeptides and Macrocycles.
Blanco MJ
Methods Mol Biol; 2019; 2001():203-233. PubMed ID: 31134573
[TBL] [Abstract][Full Text] [Related]
16. Passive Membrane Permeability of Macrocycles Can Be Controlled by Exocyclic Amide Bonds.
Hickey JL; Zaretsky S; St Denis MA; Kumar Chakka S; Morshed MM; Scully CC; Roughton AL; Yudin AK
J Med Chem; 2016 Jun; 59(11):5368-76. PubMed ID: 27120576
[TBL] [Abstract][Full Text] [Related]
17. Heteroaryl Rings in Peptide Macrocycles.
Smolyar IV; Yudin AK; Nenajdenko VG
Chem Rev; 2019 Sep; 119(17):10032-10240. PubMed ID: 31157971
[TBL] [Abstract][Full Text] [Related]
18. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
[TBL] [Abstract][Full Text] [Related]
19. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.
Marsault E; Peterson ML
J Med Chem; 2011 Apr; 54(7):1961-2004. PubMed ID: 21381769
[No Abstract] [Full Text] [Related]
20. Improving oral bioavailability of cyclic peptides by N-methylation.
Räder AFB; Reichart F; Weinmüller M; Kessler H
Bioorg Med Chem; 2018 Jun; 26(10):2766-2773. PubMed ID: 28886995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
